BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee SY, Hyun D, Cho SK, Shin SW, Jung SH, Chi SA. Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2018;41:120-9. [PMID: 28924943 DOI: 10.1007/s00270-017-1783-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Kim JG, Cho SK, Hyun D, Shin SW, Park KB, Park HS, Choo SW, Do YS, Woo SY, Baek SY. Combined transarterial chemoembolization and radiofrequency ablation for subphrenic versus nonsubphrenic hepatocellular carcinoma: a propensity score matched study. Abdom Radiol (NY) 2021;46:5735-45. [PMID: 34581928 DOI: 10.1007/s00261-021-03291-6] [Reference Citation Analysis]
2 Shin SW, Cho SK, Hyun D, Park KB, Park HS, Do YS. Guidewire-catheter induced hydrodissection to assist radiofrequency ablation for subcapsular hepatocellular carcinoma with iodized oil retention in patients with failed artificial ascites due to perihepatic adhesion. Diagn Interv Radiol 2021;27:746-53. [PMID: 34792029 DOI: 10.5152/dir.2021.21056] [Reference Citation Analysis]
3 Huang J, Huang W, Guo Y, Cai M, Zhou J, Lin L, Zhu K. Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma. Front Oncol 2021;11:638428. [PMID: 34123790 DOI: 10.3389/fonc.2021.638428] [Cited by in F6Publishing: 4] [Reference Citation Analysis]